Kamerbeek et al., 1971 - Google Patents
Prussian blue in therapy of thallotoxicosis: an experimental and clinical investigationKamerbeek et al., 1971
- Document ID
- 6590126836165577248
- Author
- Kamerbeek H
- Rauws A
- Ten Ham M
- Van Heijst A
- Publication year
- Publication venue
- Acta Medica Scandinavica
External Links
Snippet
In recent literature good results of Prussian Blue therapy in thallium poisoning in the rat have been described. In our experiments Prussian Blue in vitro exhibited a far greater adsorptive capacity for thallium than activated charcoal. Prussian Blue therapy significantly lowered …
- 229960003351 Prussian blue 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kamerbeek et al. | Prussian blue in therapy of thallotoxicosis: an experimental and clinical investigation | |
| Hall et al. | Hydroxycobalamin/sodium thiosulfate as a cyanide antidote | |
| Liu et al. | Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis | |
| Tateishi | Subacute myelo‐optico‐neuropathy: clioquinol intoxication in humans and animals | |
| Wöhler | The treatment of haemochromatosis with desferrioxamine | |
| Chhuttani et al. | Arsenical neuropathy | |
| Coffin et al. | Treatment of lead encephalopathy in children | |
| US4481195A (en) | Method for the treatment of tumors with β-glucuronidase activity dependent pharmaceuticals | |
| Herbert et al. | Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation | |
| Ramsbottom et al. | Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man | |
| Condon et al. | The cause and treatment of postvagotomy diarrhoea | |
| JPS58501676A (en) | Mixtures for supplying selenium to humans as a trace substance, as well as its use in media for cell culture, solutions for preserving organs and nutrient solutions for preserving blood components | |
| De Groot et al. | Toxicokinetic aspects of thallium poisoning. Methods of treatment by toxin elimination | |
| US5964224A (en) | Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor | |
| Howard et al. | Combined use of clofibrate and cholestyramine or DEAE Sephadex in hypercholesterolaemia | |
| WO2000021519A1 (en) | Drug preparation 'histochrome' for treating acute myocardial infarction and ischaemic heart diseases | |
| JPH04275231A (en) | Method of using super oxide dismutase for prevention and treatment of organic rejection for critical patient having multiple injury as a result of accident | |
| JPH06199695A (en) | Agent for amelioration and treatment of diabetes | |
| Robinson et al. | Effect of misoprostol on fat malabsorption in cystic fibrosis. | |
| Lieberthal et al. | Lowered serum cholesterol following the ingestion of a hydrophilic colloid | |
| Sorensen, AWS & Torben | Persistent pareses after porphyric attacks | |
| Kendig Jr et al. | Short-term antimicrobial therapy of tuberculous meningitis | |
| Horiguchi et al. | Successful treatment with clonazepam for neuroleptic‐induced akathisia | |
| Pendower | Spontaneous disappearance of gall-stones | |
| Atkinson et al. | Comparison of charcoal and attapulgite as gastrointestinal sequestrants in acute drug ingestions |